Concepedia

Jochen Schuhmacher

JS

24

Publications

1.7K

Citations

18

H-Index

1983

Active since

Affiliations

Heidelberg University(Current)

German Cancer Research Center

Research Institute of Radiology

University of Basel

University Hospital Heidelberg

Jochen Schuhmacher is an author at Heidelberg University specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1983–2007

24

Publications

24

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.

Marcus Henze, Jochen Schuhmacher, Peter Hipp et al. · PubMed · 2001 · 266 citations

, , +18

Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics

Sergey M Kipriyanov, Gerhard Moldenhauer, Jochen Schuhmacher et al. · Journal of Molecular Biology · 1999 · 194 citations

, , +10

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

Marcus Henze, Antonia Dimitrakopoulou‐Strauss, Stefanie Milker-Zabel et al. · PubMed · 2005 · 163 citations

GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.

Jochen Schuhmacher, Hanwen Zhang, Josef Doll et al. · PubMed · 2005 · 144 citations

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

Sylvie Froidevaux, Martine Calame‐Christe, Jochen Schuhmacher et al. · PubMed · 2004 · 136 citations

Rows per page

1–5 of 24